Symrise launches “nature-identical” synthetic CBD for pharma applications

Related Articles

FormattedPicture

BUSINESS NEWS

Swiss-based biotech company Evolva has released its Q3 results, announcing it has tripled its revenue with a 250% increase in comparison to the third quarter of 2021.... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

Diving into the field of infant nutrition, NutritionInsight speaks with Eurosérum, Vaneeghen, Kerry, FrieslandCampina and Symrise about the latest market trends,... Read More

FormattedPicture

FOOD RESEARCH

AI-driven health-tech company Radicle Science and Open Book Extracts (OBX) have released the results of “history’s largest clinical trial researching CBD for... Read More

FormattedPicture

FOOD RESEARCH

US-based Conagen has announced commercial production of its 99% high-purity salidroside, made via bioconversion technology. Salidroside is an active ingredient from the... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

The first research facility of its kind to be opened in Estonia, will focus on the study of functional mushrooms with an eye toward increasing knowledge and... Read More

trans